TY  - GEN
AU  - Verboon,Christine
AU  - van den Berg,Bianca
AU  - Cornblath,David R
AU  - Venema,Esmee
AU  - Gorson,Kenneth C
AU  - Lunn,Michael P
AU  - Lingsma,Hester
AU  - Van den Bergh,Peter
AU  - Harbo,Thomas
AU  - Bateman,Kathleen
AU  - Pereon,Yann
AU  - Sindrup,Søren H
AU  - Kusunoki,Susumu
AU  - Miller,James
AU  - Islam,Zhahirul
AU  - Hartung,Hans-Peter
AU  - Chavada,Govindsinh
AU  - Jacobs,Bart C
AU  - Hughes,Richard A C
AU  - van Doorn,Pieter A
TI  - Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study
SN  - 1468-330X
PY  - 2020///0706
KW  - Adult
KW  - Aged
KW  - Disability Evaluation
KW  - Drug Administration Schedule
KW  - Female
KW  - Guillain-Barre Syndrome
KW  - diagnosis
KW  - Humans
KW  - Immunoglobulin G
KW  - administration & dosage
KW  - Immunoglobulins, Intravenous
KW  - therapeutic use
KW  - Immunologic Factors
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1136/jnnp-2019-321496
ER  -